Browse Studies — Arctuva

Rare Diseases Clinical Research Network Brittle Bone Disease Consortium Longitudinal Study of Osteogenesis Imperfecta

Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta…

Osteogenesis Imperfecta

Estimated

~$10 – $750

Baylor College of MedicineNCT02432625

Phase 2

A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of AGA2115 in Adults With Type I, III, or IV Osteogenesis Imperfecta (OI)

This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.

Osteogenesis Imperfecta (OI)

Estimated

~$10 – $8,750

Angitia Incorporated LimitedNCT07062588

Phase 3

Multicenter, Safety Follow-up Study to Assess Safety of Prior Treatment With Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

The primary objective of this trial is to evaluate the safety of romosozumab in participants with osteogenesis imperfecta (OI) that have completed Study 202001…

Osteogenesis Imperfecta

Estimated

~$10 – $7,500

AmgenNCT07366086

Phase 4

Effects of Bisphosphonates on OI-Related Hearing Loss: A Pilot Study

Osteogenesis Imperfecta-related hearing loss usually occurs in individuals with mild (type I) OI and is much earlier in onset than age-related hearing loss, wi…

Osteogenesis Imperfecta

Estimated

~$10 – $6,250

Hospital for Special Surgery, New YorkNCT04152551